Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Chest. 2009 Feb 18;136(1):212–219. doi: 10.1378/chest.08-2288

Figure 2. Individual subject patterns of inflammatory mediators during the quit process.

Figure 2

Individual subject patterns of serum inflammatory mediators (associated with increased risk of CVD) during the smoking cessation process (visits 1–4) are shown for: (A) TNF; (B) sTNFRI; (C) sTNFRII; (D) sVCAM-1; (E) IL-6; and (F) CRP. Open symbols denote mediator values for individual subjects (taking NRT+bupropion) whose inflammatory mediators declined over the smoking cessation program; closed symbols denote values for individual subjects where no changes in inflammatory mediator levels were observed.